Do you suggest it's desperation - VC's finally are bored with or are exhausting the software space? Rationally, they would only invest if the incentive for sufficient return existed.

So what has changed with regard to starting a "science company"? I assume it's easier to begin prototyping and have a POC to convince investors. The issues of scaling such "science" to real-world levels is definitely more resource intensive and can be hit with more regulatory steps (biotech for example).

But what other factors have changed for "science companies" that make them more attractive investments?